Vasomedical & PEECH Trial

Vasomedical released results of its Prospective Evaluation of Enhanced External Counterpulsation in Congestive Heart Failure (PEECH) study for congestive heart failure and published results in a peer-review journal. This study found that patients with mid- to moderate-severe heart failure experienced an improvement in their New York Heart Association (NYHA) class after counterpulsation. However, the long-term safety and effects of EECP are unknown among these patients and more long-term studies are needed.

By |2017-06-14T17:56:41+00:00June 14th, 2017|Comments Off on Vasomedical & PEECH Trial
error: